Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I HIV vaccine prime-boost trial in healthy volunteers in Mozambique
PACTR201106000304583Phase 1Recruiting
- Sponsor
- Swedish Institute for Infectious Disease Control
- Start
- Jul 2011
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of EP-1090 in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Swedish Institute for Infectious Disease Control. Started Jul 2011; status: recruiting.
02
Drugs
EP-1090
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201106000304583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201106000304583.